89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 51 filers reported holding 89BIO INC in Q2 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,945,008 | -21.5% | 125,972 | -3.7% | 0.01% | -14.3% |
| Q2 2023 | $2,478,281 | +104.8% | 130,780 | +64.6% | 0.01% | +75.0% |
| Q1 2023 | $1,209,993 | +19.6% | 79,448 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $1,011,373 | +119.9% | 79,448 | 0.0% | 0.00% | +200.0% |
| Q3 2022 | $460,000 | +3.4% | 79,448 | -42.5% | 0.00% | 0.0% |
| Q2 2022 | $445,000 | -1.8% | 138,248 | +14.9% | 0.00% | 0.0% |
| Q1 2022 | $453,000 | -28.7% | 120,271 | +147.6% | 0.00% | 0.0% |
| Q4 2021 | $635,000 | -33.3% | 48,571 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $952,000 | +4.8% | 48,571 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $908,000 | -33.6% | 48,571 | -15.9% | 0.00% | -33.3% |
| Q1 2021 | $1,368,000 | -2.8% | 57,771 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,408,000 | – | 57,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |